Pulegone [89-82-7]
Referencia NB-64-46285-1g
embalaje : 1g
Marca : Neo Biotech
Pulegone (Synonyms: (+)-Pulegone)
Catalog No. TCS0102 Copy Product Info
1. Pulegone ((+)-Pulegone) has cytotoxicity followed by regenerative cell proliferation is the MOA for Pulegone-induced urothelial tumors in female rats. 2. Pulegone induces a verapamil-sensitive psychostimulant effect that appears to independ on the opening of L-type calcium channels. 3. Pulegone has negative reinforcing properties and seems to possess anxiolytic-like actions unrelated to the benzodiazepine site of the γ-aminobutyric acid type A (GABAA) receptor.
Pulegone
Copy Product InfoSynonyms (+)-Pulegone
1. Pulegone ((+)-Pulegone) has cytotoxicity followed by regenerative cell proliferation is the MOA for Pulegone-induced urothelial tumors in female rats. 2. Pulegone induces a verapamil-sensitive psychostimulant effect that appears to independ on the opening of L-type calcium channels. 3. Pulegone has negative reinforcing properties and seems to possess anxiolytic-like actions unrelated to the benzodiazepine site of the γ-aminobutyric acid type A (GABAA) receptor.

Cas No. 89-82-7
Select Batch
Appearance:Liquid
Color:Transparent
Contact us for more batch information
Product Introduction
Pulegone AI Summary
Pulegone has demonstrated significant nematicidal and insecticidal activities in various biological assays. It is effective against Meloidogyne javanica and Meloidogyne incognita J2 (root-knot nematodes) larvae, reducing larval motility with EC50 values ranging from 0.205 µL/mL to 150.0 µg/mL. Additionally, it exhibits strong insecticidal activity against Frankliniella occidentalis (western flower thrips), achieving 100% mortality at a concentration of 1 µL/45 mL, and against Sitophilus granarius (granary weevil) with a 90% mortality rate. Moreover, Pulegone is toxic to Musca domestica (house fly), causing mortality with an LD50 of 92.2 µg after 24 hours and showing activity in displacing [3H]TBOB binding to the GABA receptor in Musca domestica head homogenates by 132% at 500 µM concentration after 90 minutes of incubation. The compound also influences various physiological and biochemical parameters in the body, such as chloride levels, albumin, liver enzymes (ALT, AST, ALP, LDH), blood urea nitrogen (BUN), glucose, lipid profile (cholesterol, triglycerides), electrolytes (sodium, potassium), blood cell counts (RBC, WBC), and differential white blood cell counts (lymphocytes, eosinophils, neutrophils, monocytes, basophils). It affects hemoglobin levels, hematocrit, platelet count, and mean cell volume, suggesting potential impacts on multiple physiological systems and processes..
Note: Summary generated by AI. Data source: ChEMBL 
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | 1. Pulegone ((+)-Pulegone) has cytotoxicity followed by regenerative cell proliferation is the MOA for Pulegone-induced urothelial tumors in female rats. 2. Pulegone induces a verapamil-sensitive psychostimulant effect that appears to independ on the opening of L-type calcium channels. 3. Pulegone has negative reinforcing properties and seems to possess anxiolytic-like actions unrelated to the benzodiazepine site of the γ-aminobutyric acid type A (GABAA) receptor. |
| Synonyms | (+)-Pulegone |
| Molecular Weight | 152.23 |
| Formula | C10H16O |
| Cas No. | 89-82-7 |
| Smiles | C[C@@H]1CCC(=C(C)C)C(=O)C1 |
| Relative Density. | 0.937 g/mL at 25°C(lit.) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Pure form: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 200 mg/mL (1313.8 mM), Sonication is recommended. ![]() | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 2.5 mg/mL (16.42 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | ||||||||||||||||||||||||||||||||||||


